Low Dead Space Needle: How Design and Manufacturing Reduce Residual Volume
When residual volume becomes part of injection performance
A small amount of liquid can remain inside a needle after injection. In dose-sensitive systems, that residual volume becomes part of the overall device design. A low dead space needle reduces unnecessary internal space so that more of the prepared liquid can pass through the needle during use.

What Makes a Needle “Low Dead Space”?
Dead space is the internal area in which liquid may remain after an injection has been completed. In a detachable needle, this volume is mainly associated with the hub cavity, the needle lumen, and the transition area between the syringe outlet and the needle tube.
A low dead space needle is therefore not defined by one isolated feature. Hub geometry, needle tube position, lumen size, adhesive placement, and connection design all contribute to the final residual volume. Reducing unnecessary cavity space helps limit the amount of prepared liquid that remains inside the component after the syringe plunger reaches the end of its stroke.

How Mekon Controls the Key Details of a Low Dead Space Needle
For Mekon, low dead space development begins with the complete needle assembly rather than the hub alone. The tube, hub, adhesive, insertion depth, and mating connection are reviewed together so that the finished component can meet both residual-volume and handling requirements.
Where Low Dead Space Needles May Be Considered
Low dead space needles may be considered for injection systems in which residual volume is an important design factor. Examples can include certain vaccine delivery systems, biologic injections, specialty injectable products, self-injection devices, and fine-dose drug delivery platforms.
The design is especially relevant when a needle must be matched with a specific syringe outlet, injector, cartridge, or delivery device. In these projects, the needle should not be evaluated as a stand-alone component. Connection fit, flow path, residual volume, penetration performance, and assembly method need to be reviewed together.
From Development Samples to Repeat Production
Low residual volume can be affected by small changes in manufacturing. For this reason, Mekon connects design review with process control from the beginning of the project. Critical dimensions and assembly conditions identified during development are carried into production inspection and batch control.
Mekon Manufacturing and OEM/ODM Support
Shanghai Mekon Medical Devices Co., Ltd. combines needle tube processing, precision grinding, hub assembly, cleaning, inspection, packaging, and sterilization support within one development and manufacturing chain. This allows the tube and hub to be treated as one functional injection component rather than as separate purchased parts.
For OEM and ODM projects, Mekon can review needle tube dimensions, wall type, hub structure, insertion position, adhesive control, and connection design according to the customer’s syringe or delivery platform. Development controls can then be transferred into repeat manufacturing to support stable residual volume, flow, connection, and finished-product quality.
Production and quality activities are managed under Mekon’s ISO 13485 quality management system, with support for project-specific packaging, sterilization, labeling, and technical documentation requirements.
A low dead space needle should combine controlled hub geometry, a stable needle lumen, precise tube positioning, and reliable assembly. Mekon supports both standard low dead space needle supply and customized development for specific syringe and drug delivery applications.
Explore the Low Dead Space Needle








